Pharma Journalist -

Jecure Therapeutics Inc., a biotechnology company with novel drug discovery programs targeting serious inflammatory diseases, announced a definitive agreement by which it will be…
Read More...

AiPing Pharmaceutical, Inc. announced that it has completed the sale of three ibuprofen Abbreviated New Drug Applications (ANDAs) in the U.S. to Shandong Xinhua Pharmaceutical Co., Ltd.…
Read More...

SMI REPORTS: SMi Group speak to James Mellman, Device Manager, Novartis, Co-Chair of Pre-Filled Syringes 2019 SMi Group are delighted to have James Mellman, Device Manager, Novartis,…
Read More...

Octapharma announced that the Swiss Agency for Therapeutic Products, Swissmedic, granted marketing authorization to its new fibrinogen concentrate product fibryga for the treatment of…
Read More...

CBT Pharmaceuticals (CBT) and Zhejiang Bossan Pharmaceutical Co., Ltd (Bossan) announced that they have entered into a clinical collaboration and license agreement to develop their…
Read More...

Edge Therapeutics and PDS Biotechnology Corporation announced that their respective boards of directors have approved a definitive merger agreement. The merger is expected to create a…
Read More...

Telix Pharmaceuticals Limited has announced the acquisition of Belgium-based Advanced Nuclear Medicine Ingredients (ANMI) SA for €5.15m in cash and shares. The acquisition of ANMI…
Read More...

Fusion Antibodies plc, experts in antibody engineering and Analytics Engines, an advanced data analytics company, have announced a strategic collaboration to incorporate machine…
Read More...

Vir Biotechnology, Inc. and Alnylam Pharmaceuticals, Inc. announced the initiation of a Phase 1/2 study of VIR-2218, a novel, investigational RNA interference (RNAi) therapeutic for the…
Read More...

Machavert Pharmaceuticals, a drug development company focused on bioactive phospholipid therapeutics for the treatment of cancer, recently reported impressive preclinical results. The…
Read More...